(Q51097851)

29 March 2018

title

Cyclophosphamide given after active specific immunization augments antitumor immunity by modulation of Th1 commitment of CD4+ T cells. (English)

1 reference

29 March 2018

0 references

Li L

1

1 reference

29 March 2018

Okino T

2

1 reference

29 March 2018

Sugie T

3

1 reference

29 March 2018

Yamasaki S

4

1 reference

29 March 2018

Ichinose Y

5

1 reference

29 March 2018

Kanaoka S

6

1 reference

29 March 2018

Kan N

7

1 reference

29 March 2018

Imamura M

8

1 reference

29 March 2018

publication date

1 April 1998

1 reference

29 March 2018

Journal of Surgical Oncology

published in

1 reference

29 March 2018

volume

67

1 reference

29 March 2018

issue

4

1 reference

29 March 2018

page(s)

221-227

1 reference

29 March 2018

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Effect of Cyclophosphamide on Immunological Control Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Immunoregulatory effects of CD4+ T helper subsets in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Depressed T-cell reactivity and suppressor activity of lymoid cells from cyclophosphamide-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9098%28199804%2967%3A4%3C221%3A%3AAID-JSO3%3E3.0.CO%3B2-A

10.1002/(SICI)1096-9098(199804)67:4<221::AID-JSO3>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

29 March 2018

1 reference

29 March 2018